Home Top Movers Here is why R1 RCM Inc (RCM) stock price fluctuated on Tuesday?

Here is why R1 RCM Inc (RCM) stock price fluctuated on Tuesday?

R1 RCM Inc. (RCM) shares lost 4.09% in the after-market session on Tuesday, May 25, 2021, and closed at $24.37 per share. Earlier, in the morning session, RCM’s stock gained 0.47% to close the session at $25.41 per share. RCM shares have risen 144.33% over the last 12 months, and they have moved up  3.88% in the past week. Over the past three months, the stock has lost 11.46%, while over the past six months, it has added 25.36%.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Let’s see is there any reason behind its mixed performance on Tuesday?

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Commencing Secondary Offering of stock selling

On May 25, 2021, R1 RCM Inc commenced the underwritten offering of an aggregate of 15,000,000 shares of its common stock by selling stockholders.

Read More

The selling stockholders are TCP-ASC ACHI Series LLLP (“TCP-ASC”), a Delaware series limited liability limited partnership jointly owned by Ascension Health Alliance and investment funds affiliated with TowerBrook Capital Partners, L.P., and Joseph Flanagan, the President and Chief Executive Officer of the Company.

R1 RCM will not receive any of the proceeds from the sale of common stock because it’s not selling any shares in the offering.

R1 RCM Inc and Mednax agreement

On May 17, 2021, R1 RCM Inc and Mednax, Inc. entered into an agreement that will make R1 the primary provider of enterprise revenue cycle management services for Mednax.

R1’s end-to-end revenue cycle model will improve the overall patient experience and will enhance clinical, financial, and operational performance for Mednax and its hospital partners.

Financial results announcement

On May 04, 2021, R1 RCM Inc reported its financial results for the three months ended March 31, 2021.

Q1 2021 financial results

  • R1 RCM reported revenue of $342.6 million for Q1 2021 compared to $320.5 million in Q1 2020.
  • The company spent $305.8 million in operating expenses in Q1 2021 compared to $288.1 million in Q1 2020.
  • In Q1 2021, GAAP net income was $25.8 million compared to $18.2 million in Q1 2020.
  • Net income (loss) per common share was $2.37 for a basic and diluted share in Q1 2021 compared to $0.06 basic and $0.05 diluted in Q1 2020
  • Adjusted EBITDA was $80.4 million in Q1 2021 compared to $18.2 million in Q1 2020.
  • As of March 31, 2021, R1 RCM had cash and cash equivalents of $103.5 million, compared to $173.8 million on December 31, 2020.

FY-2021 financial outlook

For 2021, R1 is expecting

  • Revenue of between $1,410 million and $1,460 million
  • GAAP operating income of $135 million to $155 million
  • Adjusted EBITDA of $315 million to $330 million

Acquisition of VisitPay

On May 04, 2021, R1 RCM Inc entered into a definitive agreement to acquire VisitPay, for approximately $300 million in cash.

VisitPay is the leading digital payment solution provider and the nation’s largest and most innovative health systems used its cloud-based platform to transform the payment experience and drive both improved patient satisfaction and higher collection yield.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

The secondary offering of stock selling could be the reason behind its fluctuation on Tuesday. We have no other recent news to justify its mixed performance on Tuesday.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam